Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines

BACKGROUND: We observed that paclitaxel altered the pharmacokinetic properties of gemcitabine in patients with non-small cell lung cancer (NSCLC) and limited the accumulation of gemcitabine and its metabolites in various primary and immortalized human cells. Therefore, we classified the drug-drug in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shord, Stacy S, Patel, Shitalben R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708129/
https://www.ncbi.nlm.nih.gov/pubmed/19500405
http://dx.doi.org/10.1186/1756-9966-28-76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2708129/
https://www.ncbi.nlm.nih.gov/pubmed/19500405
http://dx.doi.org/10.1186/1756-9966-28-76

Ejemplares similares